Ridruejo, E., Garcia Agudo, R., Mendizabal, M., Aoufi Rabih, S., Dixit, V., Silva, M., & Fabrizi, F. (2019). Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. Web
Citación estilo ChicagoRidruejo, Ezequiel, Rebeca Garcia Agudo, Manuel Mendizabal, Sami Aoufi Rabih, Vivek Dixit, Marcelo Silva, and Fabrizio Fabrizi. Efficacy and Safety of Direct-acting Antiviral Agents for HCV in Mild-to-moderate Chronic Kidney Disease. 2019.
Cita MLARidruejo, Ezequiel, et al. Efficacy and Safety of Direct-acting Antiviral Agents for HCV in Mild-to-moderate Chronic Kidney Disease. 2019.
Precaución: Estas citas no son 100% exactas.